ClinicalTrials.Veeva

Menu

Phenotypic Characteristics of Superlean Individuals Including Gut Microbiome

S

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Status

Completed

Conditions

Thinness
Health Behavior

Treatments

Other: Observation without intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05804929
SIAT-IRB-221115-H0628

Details and patient eligibility

About

The goal of this observational study is to build on our previous work to further characterise the phenotype of superlean individuals (BMI < 18.5) when compared to normal BMI people (BMI 21.5 to 25). This will include characterising the body composition, food intake behaviour, circulating hormone levels, genetics and characteristics of the gut microbiota. The investigators expect to recruit up to 200 healthy superlean and control volunteers respectively,

Full description

The focus of this work is to characterise the phenotype and genotype of individuals who have low BMI ( < 18.5) but are otherwise healthy and do not have eating disorders. The investigators term this group 'superlean' individuals. The study is observational and the investigators aim to establish a healthy superlean cohort,and use the combined metagenomic and metabolomic multi-omics analysis techniques, combined with imaging and physiological measurements, to focus on the correlation between gut microbiota characteristics and metabolism in superlean population. The investigators expect to recruit up to 200 healthy superlean and control volunteers (BMI 21.5 to 25) respectively, to explore the microbiota characteristics and differences between control and healthy superlean populations by measuring the basic physical indicators and metabolic parameters. This will include analyzing the postprandial hormonal changes, appetite differences, and changes in the gut microbiome and serum metabolome in the two groups of volunteers, establishing the relationship between the gut microbiota and the metabolite and metabolic phenotypes of the body, and exploring the gut microbiota.

Enrollment

104 patients

Sex

All

Ages

25 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Control group (21.5≤ BMI<25), Superlean group (BMI≤18.5)
  • Age between 25-40 years old

Exclusion criteria

  • Having metabolic diseases or eating disorders
  • Recent weight loss due to various disease causes
  • Being treated for weight loss
  • Having an infectious disease
  • Pregnant and lactating women
  • People with blood sickness, pathological hypo- or hypertension
  • People suffering from claustrophobia
  • No metal implants in the body
  • Use of antibiotics, probiotics, oral laxatives, etc. within 8 weeks

Trial design

104 participants in 2 patient groups

Control
Description:
21.5≤BMI\<25, age between 25-40 years old, 200subjects.
Treatment:
Other: Observation without intervention
Superlean
Description:
BMI≤18.5, age between 25-40 years old, 200 subjects.
Treatment:
Other: Observation without intervention

Trial contacts and locations

1

Loading...

Central trial contact

Ying Yu, PhD; John R Speakman, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems